SARAH BRANNAN: Open Payments
NPI 1225776958 · ELMHURST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,107 in 43 payments from 10 companies in 2025. Trend: 2023 $806 · 2024 $1,648 · 2025 $1,107
Food & beverage: $1,107
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 16 | $415 |
| Otsuka America Pharmaceutical, Inc. | 3 | $160 |
| Neurocrine BioSciences, Inc. | 6 | $128 |
| Janssen Pharmaceuticals, Inc | 4 | $98 |
| Teva Pharmaceuticals USA, Inc. | 5 | $97 |
| Alkermes, Inc. | 3 | $84 |
| ABBVIE INC. | 2 | $49 |
| Lundbeck LLC | 2 | $39 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
Products named: COBENFY, ABILIFY MAINTENA, INGREZZA, INVEGA SUSTENNA, ARISTADA, UZEDY, VRAYLAR, ABILIFY ASIMTUFII.
Industry payments across NY — which companies pay providers there.
